Impaired fasting glucose (IFG) as a risk factor for diabetes five year follow-up

被引：0
|
作者：
Wojcik, J [1 ]
Czupryniak, L [1 ]
Saryusz-Wolska, M [1 ]
Pawlowski, M [1 ]
Milosz, D [1 ]
Loba, J [1 ]
机构：
[1] Med Univ Lodz, Diabetol & Metab Dis Dept, Lodz, Poland
来源：
DIABETOLOGIA | 2005年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
680
引用
收藏
页码：A248 / A248
页数：1
相关论文
共 50 条
  • [31] VALUE OF SIMPLE CLINICAL AND BIOCHEMICAL PARAMETERS IN PREDICTING DIABETES AMONG INDIVIDUALS WITH IMPAIRED FASTING GLUCOSE (IFG)
    Hettiarachchi, Manjula D.
    Weeraratne, Tilak
    Herath, H. M. M.
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 400 - 400
  • [32] Impaired fasting glucose is not a risk factor for cardiovascular mortality
    Weitzman, S
    DIABETES CARE, 1999, 22 (12) : 2104 - 2104
  • [33] Serum lipid and hsCRP levels in prediabetes - impaired fasting glucose (IFG) and impaired glucose tolerance (IGT)
    Chakarova, Nevena
    Tankova, Tsvetalina
    Atanassova, Iliana
    Dakouska, Lilia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 86 (01) : 56 - 60
  • [34] Gender differences in the prevalence of impaired fasting glucose (IFG) in healthy Thai
    Athirakul, K.
    Anuras, S.
    Lausoontornsiri, W.
    DIABETOLOGIA, 2006, 49 : 195 - 196
  • [35] NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: An eleven year follow-up study
    Adams, Leon A.
    Waters, Oliver R.
    Knuiman, Matthew
    Elliott, Robert
    Olynyk, John K.
    HEPATOLOGY, 2007, 46 (04) : 744A - 744A
  • [36] Insulin secretion and insulin action in subjectswith impaired fasting glucose (IFG) and impaired glucose tolerance (IGT)
    Abdul-Ghani, Muhammad
    Jenkinson, Christopher
    Richardson, Dawn
    Devjittripathy
    Defronzo, Ralph
    DIABETES, 2006, 55 : A321 - A321
  • [37] Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up
    Qiao, Q
    Jousilahti, P
    Eriksson, J
    Tuomilehto, J
    DIABETES CARE, 2003, 26 (10) : 2910 - 2914
  • [38] Risks of borderline liver enzyme abnormalities to the incidence of impaired fasting glucose and diabetes mellitus: a 7 year follow up study of workers
    Yu, Jin-Hyun
    Kim, Jin-Seok
    Lee, Mee-Ra
    Yoon, Seong-Yong
    Cho, Seong-Yong
    Yoo, Seung-Hyun
    Kim, Boo-Il
    ANNALS OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2016, 28
  • [39] Effects of AGI-1067 on cardiovascular (CV) risk in patients with type 2 diabetes or impaired fasting glucose (IFG) in the ARISE trial
    McMurray, John J.
    Tardif, Jean-Claude
    Klug, Eric
    Fleming, Alexander G.
    Long, Walker A.
    Small, Robert
    Pfeffer, Marc A.
    DIABETES, 2008, 57 : A571 - A571
  • [40] Frequency of Diabetes (DM), Impaired Fasting Glucose (IFG) and Glucose Intolerance (GI) in High Risk Groups Identified by FINDRISK Survey in Puebla City, Mexico
    Garcia-Alcala, Hector
    Hirales-Tamez, Omara
    DIABETES, 2010, 59 : A612 - A612
12345